Medical History, Clinical Features, Treatment Outcome and Its Predictors Among Infectious Keratitis Patients in Jimma University Medical Center, Southwest Ethiopia: Prospective Observational Study

References

• Khurana A. Community Ophthalmology in Comprehensive Ophthalmology, Chapter 20. New Delhi: New Age International Limited Publisher; 2007:443–457.
   Google Scholar
• Collier SA, Gronostaj MP, MacGurn AK, et al. Estimated burden of keratitis—United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(45):1027.
   PubMed Web of Science ®Google Scholar
• Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008;27(1):22–27. doi:10.1097/ICO.0b013e318156caf2
   PubMed Web of Science ®Google Scholar
• Srigyan D, Gupta M, Behera HS. Keratitis: an inflammation of cornea. EC Ophthalmol. 2017;6(6):7.
   Google Scholar
• Song X, Xie L, Tan X, et al. A multi-center, cross-sectional study on the burden of infectious keratitis in China. PLoS One. 2014;9(12):e113843. doi:10.1371/journal.pone.0113843
   PubMed Web of Science ®Google Scholar
• Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79:214–221.
   PubMed Web of Science ®Google Scholar
• Robles-Contreras A, Perez-Cano HJ, Babayan-Sosa A, Baca-Lozada O. Bacterial Keratitis infection: a battle between virulence factors and the immune response. Common Eye Infect Intech Open. 2013.
   Google Scholar
• Foster C. Fungal keratitis. Infect Dis Clin North Am. 1992;6(4):851–857. doi:10.1016/S0891-5520(20)30486-4
   Web of Science ®Google Scholar
• Norina T, Raihan S, Bakiah S, Ezanee M, Liza-Sharmini A, Wan Hazzabah W. Microbial keratitis: aetiological diagnosis and clinical features in patients admitted to Hospital Universiti Sains Malaysia. Singapore Med J. 2008;49(1):67–71.
   Web of Science ®Google Scholar
• Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol. 2009;93(5):563–568. doi:10.1136/bjo.2008.148494
   PubMed Web of Science ®Google Scholar
• Evans T. Socioeconomic consequences of blinding onchocerciasis in west Africa. Bull World Health Organ. 1995;73(4):495.
   Web of Science ®Google Scholar
• Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124(11):1678–1689. doi:10.1016/j.ophtha.2017.05.012
   PubMed Web of Science ®Google Scholar
• Chirinos-Saldaña P, de Lucio VMB, Hernandez-Camarena JC, et al. Clinical and microbiological profile of infectious keratitis in children. BMC Ophthalmol. 2013;13(1):54. doi:10.1186/1471-2415-13-54
   Web of Science ®Google Scholar
• Burton MJ, Pithuwa J, Okello E, et al. Microbial keratitis in East Africa: why are the outcomes so poor? Ophthalmic Epidemiol. 2011;18(4):158–163. doi:10.3109/09286586.2011.595041
   PubMed Web of Science ®Google Scholar
• Whitcher JP, Srinivasan M. Corneal ulceration in the developing world—a silent epidemic. Br J Ophthalmol. 1997;81(8):622–623. doi:10.1136/bjo.81.8.622
   PubMed Web of Science ®Google Scholar
• Ansari Z, Miller D, Galor A. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep. 2013;7(3):209–218. doi:10.1007/s12281-013-0150-1
   PubMedGoogle Scholar
• WHO. Guidelines for the management of corneal ulcer at primary, secondary, and tertiary care health facilities in the South-East Asia Region. 1–3SEA/Opthal/126; 2004.
   Google Scholar
• Cao J, Yang Y, Yang W, et al. Prevalence of infectious keratitis in Central China. BMC Ophthalmol. 2014;14(1):43. doi:10.1186/1471-2415-14-43
   Web of Science ®Google Scholar
• O’Brien KS, Lietman TM, Keenan JD, Whitcher JP. Microbial keratitis: a community eye health approach. Community Eye Health. 2015;28(89):1.
   PubMedGoogle Scholar
• Al-Mujaini A, Al-Kharusi N, Thakral A, Wali UK. Bacterial keratitis: perspective on epidemiology, clinico-pathogenesis, diagnosis and treatment. Sultan Qaboos Univ Med J. 2009;9(2):184.
   Google Scholar
• Brown L. Resistance to ocular antibiotics: an overview. Clin Exp Optometry. 2007;90(4):258–262. doi:10.1111/j.1444-0938.2007.00154.x
   PubMed Web of Science ®Google Scholar
• Sharma S. Antibiotic resistance in ocular bacterial pathogens. Indian J Med Microbiol. 2011;29(3):218. doi:10.4103/0255-0857.83903
   Web of Science ®Google Scholar
• Team EE. CDC publishes report on antibiotic resistance threats in the United States for the first time. Euro surveillance bulletin Europeen sur les maladies transmissibles. 2013;18:38.
   Google Scholar
• Anagaw B, Biadglegne F, Belyhun Y, Mulu A. Bacteriology of ocular infections and antibiotic susceptibility pattern in Gondar University Hospital, north west Ethiopia. Ethiop Med J. 2011;49(2):117–123.
   Google Scholar
• Ibanga A, Asana U, Nkanga D, Duke R, Etim B, Oworu O. Indications for eye removal in southern Nigeria. Int Ophthalmol. 2013;33(4):355–360. doi:10.1007/s10792-012-9700-8
   PubMed Web of Science ®Google Scholar
• Saeed N, Khan MD. The challenge of microbial keratitis in Pakistan. Pak J Ophthalmol. 2010;26:3.
   Google Scholar
• Titiyal JS, Negi S, Anand A, Tandon R, Sharma N, Vajpayee RB. Risk factors for perforation in microbial corneal ulcers in north India. Br J Ophthalmol. 2006;90(6):686–689. doi:10.1136/bjo.2005.079533
   PubMed Web of Science ®Google Scholar
• Aklilu A, Bitew A, Dessie W, et al. Prevalence and drug susceptibility pattern of bacterial pathogens from ocular infection in St. Paul’s Hospital Millennium Medical College, Ethiopia. J Bacteriol Mycol. 2018;5(8):1085.
   Google Scholar
• Amsalu A, Abebe T, Mihret A, Delelegne D, Tadesse E. Potential bacterial pathogens of external ocular infections and their antibiotic susceptibility pattern at Hawassa University teaching and referral Hospital, Southern Ethiopia. Afr J Microbiol Res. 2015;9(14):1012–1019. doi:10.5897/AJMR2014.7282
   Google Scholar
• Shiferaw B, Gelaw B, Assefa A, Assefa Y, Addis Z. Bacterial isolates and their antimicrobial susceptibility pattern among patients with external ocular infections at Borumeda hospital, Northeast Ethiopia. BMC Ophthalmol. 2015;15(1):103. doi:10.1186/s12886-015-0078-z
   Web of Science ®Google Scholar
• Tesfaye T, Beyene G, Gelaw Y, Bekele S, Saravanan M. Bacterial profile and antimicrobial susceptibility pattern of external ocular infections in Jimma University specialized hospital, Southwest Ethiopia. Am J Infect Dis Microbiol. 2013;1(1):13–20. doi:10.12691/ajidm-1-1-3
   Google Scholar
• Teweldemedhin M, Gebreyesus H, Atsbaha AH, Asgedom SW, Saravanan M. Bacterial profile of ocular infections: a systematic review. BMC Ophthalmol. 2017;17(1):212. doi:10.1186/s12886-017-0612-2
   PubMed Web of Science ®Google Scholar
• Upadhyay MP, Karmacharya PC, Koirala S, et al. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol. 1991;111(1):92–99. doi:10.1016/S0002-9394(14)76903-X
   PubMed Web of Science ®Google Scholar
• Kibret T, Bitew A. Fungal keratitis in patients with corneal ulcer attending Minilik II Memorial Hospital, Addis Ababa, Ethiopia. BMC Ophthalmol. 2016;16(1):148. doi:10.1186/s12886-016-0330-1
   Web of Science ®Google Scholar
• Anutarapongpan O, Brien TP. Update on management of fungal keratitis. Clin Microbiol Open Access. 2005.
   Google Scholar
• Choudhary P, Chalisgaonkar C, Lakhtakia S, Dwivedi A, Khare V. A clinical study of pattern, complications, and visual outcome of viral keratitis. Int J Med Sci Public Health Online. 2017;6:6.
   Google Scholar
• Gebremariam TT, Alemu TA, Daba KT. Bacteriology and risk factors of bacterial keratitis in Ethiopia. Health Sci J. 2015;9(5):1.
   Google Scholar
• Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology. 2007;114(9):1622–1629. doi:10.1016/j.ophtha.2006.12.011
   PubMed Web of Science ®Google Scholar
• Morlet N, Minassian D, Butcher J, Group OS. Risk factors for treatment outcome of suspected microbial keratitis. Br J Ophthalmol. 1999;83(9):1027–1031. doi:10.1136/bjo.83.9.1027
   Web of Science ®Google Scholar
• Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85(7):842–847. doi:10.1136/bjo.85.7.842
   PubMed Web of Science ®Google Scholar
• Uchmanowicz B, Jankowska EA, Uchmanowicz I, Morisky DE. Self-reported medication adherence measured with morisky medication adherence scales and its determinants in hypertensive patients aged ≥60 years: a systematic review and meta-analysis. Front Pharmacol. 2019;10:10. doi:10.3389/fphar.2019.00168
   Web of Science ®Google Scholar
• Gopinathan U, Sharma S, Garg P, Rao GN. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol. 2009;57(4):273. doi:10.4103/0301-4738.53051
   PubMed Web of Science ®Google Scholar
• Ng AL-K, To KK-W, Yuen LH, et al. Predisposing factors, microbial characteristics, and clinical outcome of microbial keratitis in a tertiary centre in Hong Kong: a 10-year experience. J Ophthalmol. 2015;2015.
   Web of Science ®Google Scholar
• Mun Y, Kim MK, Oh JY. Ten-year analysis of microbiological profile and antibiotic sensitivity for bacterial keratitis in Korea. PLoS One. 2019;14:3. doi:10.1371/journal.pone.0213103
   Web of Science ®Google Scholar
• Chidambaram JD, Venkatesh Prajna N, Srikanthi P, et al. Epidemiology, risk factors, and clinical outcomes in severe microbial keratitis in South India. Ophthalmic Epidemiol. 2018;25(4):297–305. doi:10.1080/09286586.2018.1454964
   PubMed Web of Science ®Google Scholar
• Kaye S, Tuft S, Neal T, et al. Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51(1):362–368. doi:10.1167/iovs.09-3933
   PubMed Web of Science ®Google Scholar
• Khadka S, Chaudhary M, Thapa M. Evaluation of risk factors and treatment outcome of microbial keratitis in a tertiary eye center. Sudanese J Ophthalmol. 2018;10(1):25. doi:10.4103/sjopthal.sjopthal_5_18
   Google Scholar
• Shah SIA, Shah SA, Rai P, Katpar NA, Abbasi SA, Soomro AA. Visual outcome in patients of keratomycosis, at a tertiary care centre in Larkana, Pakistan. J Pak Med Assoc. 2017;67(7):1035–1038.
   Web of Science ®Google Scholar
• Lavinsky F, Avni-Zauberman N, Barequet IS. Clinical characteristics and outcomes of patients admitted with presumed microbial keratitis to a tertiary medical center in Israel. Arq Bras Oftalmol. 2013;76(3):175–179. doi:10.1590/S0004-27492013000300009
   PubMed Web of Science ®Google Scholar
• Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M. Risk factors for treatment outcome in fungal keratitis. Ophthalmology. 2006;113(4):526–530. doi:10.1016/j.ophtha.2005.10.063
   PubMed Web of Science ®Google Scholar
• Tananuvat N, Punyakhum O, Ausayakhun S, Chaidaroon W. Etiology and clinical outcomes of microbial keratitis at a tertiary eye-care center in northern Thailand. J Med Assoc Thai. 2012;95(Suppl 4):S8–17.
   PubMedGoogle Scholar
• Dhakwa K, Sharma M, Bajimaya S, Dwivedi A, Rai SK. Causative organisms in microbial keratitis, their sensitivity pattern and treatment outcome in western Nepal. Nepalese J Ophthalmol. 2012;4(1):119–127. doi:10.3126/nepjoph.v4i1.5863
   Google Scholar
• Poole T, Hunter D, Maliwa E, Ramsay A. Aetiology of microbial keratitis in northern Tanzania. Br J Ophthalmol. 2002;86(8):941–942. doi:10.1136/bjo.86.8.941
   PubMed Web of Science ®Google Scholar
• Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010;128(6):672–678. doi:10.1001/archophthalmol.2010.102
   PubMedGoogle Scholar
• Prajna NV, Krishnan T, Mascarenhas J, et al. Predictors of outcome in fungal keratitis. Eye. 2012;26(9):1226. doi:10.1038/eye.2012.99
   Web of Science ®Google Scholar
• Zapp D, Loos D, Feucht N, et al. Microbial keratitis-induced endophthalmitis: incidence, symptoms, therapy, visual prognosis and outcomes. BMC Ophthalmol. 2018;18(1):112. doi:10.1186/s12886-018-0777-3
   Web of Science ®Google Scholar
• Arunga S, Asiimwe A, Olet EA, et al. Traditional eye medicine use in microbial keratitis in Uganda: a mixed methods study. Wellcome Open Res. 2019;4.
   Google Scholar
• Patwardhan A, Khan M. Topical ciprofloxacin can delay recovery from viral ocular surface infection. J R Soc Med. 2005;98(6):274–275. doi:10.1177/014107680509800610
   Web of Science ®Google Scholar
• Wilhelmus KR, Abshire RL. Corneal ciprofloxacin precipitation during bacterial keratitis. Am J Ophthalmol. 2003;136(6):1032–1037. doi:10.1016/S0002-9394(03)00636-6
   Web of Science ®Google Scholar
• Pinazo-Durán MD, Zanón-Moreno V, García-Medina JJ, Arévalo JF, Gallego-Pinazo R, Nucci C. Eclectic ocular comorbidities and systemic diseases with eye involvement: a review. Biomed Res Int. 2016.
   Web of Science ®Google Scholar